Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Wenisch

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Infection|April 25, 2012
A prospective cohort study on hospital mortality due to Clostridium difficile infectionJ M Wenisch, D Schmid, G Tucek, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 3, 2012
Hospital-acquired Clostridium difficile infection: determinants for severe diseaseJ M Wenisch, D Schmid, H-W Kuo, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Doripenem Treatment during Continuous Renal Replacement TherapyM G Vossen, J M Wenisch, A Maier-Salamon, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2018
Elimination of Doripenem during Dialysis and Pharmacokinetic Evaluation of Posthemodialysis Dosing for Patients Undergoing Intermittent Renal Replacement TherapyM G Vossen, L Ehmann, S Pferschy, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Infection|April 25, 2012
A prospective cohort study on hospital mortality due to Clostridium difficile infectionJ M Wenisch, D Schmid, G Tucek, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 3, 2012
Hospital-acquired Clostridium difficile infection: determinants for severe diseaseJ M Wenisch, D Schmid, H-W Kuo, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Doripenem Treatment during Continuous Renal Replacement TherapyM G Vossen, J M Wenisch, A Maier-Salamon, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2018
Elimination of Doripenem during Dialysis and Pharmacokinetic Evaluation of Posthemodialysis Dosing for Patients Undergoing Intermittent Renal Replacement TherapyM G Vossen, L Ehmann, S Pferschy, et al.
Pageof 1